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Background: Injecting drug users are at high risk of HIV infection globally. Research 
related to female drug users is rare in Kenya, yet it is required to inform the development of 
gender-sensitive HIV prevention and harm reduction services in East Africa, where injecting 
drug use is on the rise.  
Methods: This study aimed to document the nature of HIV risks encountered by women who 
inject drugs in the Mombasa and Kilifi, Kenya. Secondary data analysis was conducted on an 
existing dataset from a 2015 primary qualitative study involving 24 interviews and 3 focus 
group discussions with 45 women who inject drugs. These were complemented with five 
interviews with key stakeholders involved in the provision of services to women who inject 
drugs. Guided by the social ecology theory, a thematic analysis was conducted to identify the 
nature of HIV risks and their underlying determinants.  
Results: HIV risk behaviours fell into two broad categories: unsafe injecting and unprotected 
sex. These risks occurred in the form of sharing of needles, unprotected oral, anal and vaginal 
sex, sexual assaults, injecting drug use during sex, sex work, and other types of transactional 
sex. The primary determinants underlying these risks were a low-risk perception, inequitable 
gender power, economic pressures, and poor availability of needles and condoms. These 
social-ecological these determinants did not exist in isolation, but intersected with each other 
to create powerful influences which exposed women to HIV. Social-ecological determinants 
exerted constant influence and created a persistent ‘HIV risk environment’ that was 
involuntarily experienced by women. 
Conclusion: Individual, interpersonal, and societal-structural factors intersect to produce 
HIV risk behaviours. As a minimum, these risks will require a combination of multifaceted 
micro-level interventions including self-efficacy training, risk assessment skills, couple 
counselling, and universal access to the recommended harm reduction package. In addition, 
the current focus on micro-level interventions in Kenya needs to shift to incorporate macro-
level interventions, including livelihood, employability, and gender norms-transforming 
interventions, to mitigate economic and gender-related drivers of HIV risks. In the Kenyan 
context, injecting drug use during sex work is emerging as an increasingly important HIV 
risk behaviour needing to be addressed.  
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Background 
Kenya is one of the countries most affected by HIV globally [1]. It has a generalized HIV 
epidemic, and a national prevalence of 5.6% [2]. There are 1.6 million people living with 
HIV nationally, majority of whom acquired it via unprotected heterosexual sex [3, 4]. An 
additional 100,000 new HIV infections occur annually, 80% of these being among adults [4]. 
Despite these stark statistics, epidemiological data shows that HIV prevalence is on a decline 
in Kenya, having peaked at a prevalence of 10.5% in the late 1990s [4]. Similarly, HIV 
incidence has been on decline from an annual peak of 116,000 infections in 2009 [4].  
 
In-order to sustain these gains in HIV epidemic, emerging epicenters of high incidence will 
need to be continually addressed. For instance, although heterosexual sex has historically 
been the main driver of HIV epidemic in Kenya, injecting drug use is emerging as an 
important source of new HIV infections. The first modes-of-HIV-transmission study in 
Kenya to include injecting drug users was conducted in 2008. It found that injecting drug use 
contributed 3.8% of HIV cases nationally [3]. This relatively low contribution of injecting 
drug use to the national HIV prevalence has contributed to an inadvertent neglect of people 
who inject drugs (PWID) in Kenya [5]. However, the importance of injecting drug use comes 
to the fore when HIV infection within PWID themselves is considered. For instance, recent 
modelling studies estimated that 18.3% of the 18,327 injecting drug users nationally were 
infected with HIV [4, 6]. This prevalence is more than three times the national rate [2].  
 
A number of other recent studies have support the view that injecting drug use is rapidly 
rising in Kenya and other parts of east Africa [7-9]. In their review of 21 high HIV epidemic 
countries globally Petersen et al. [10] concluded that ‘while injecting drug use is relatively 
rare in sub-Saharan Africa, it is the main driver of HIV in Mauritius and Kenya’. Indeed, the 
high prevalence of HIV among Kenyan PWID is similar to that reported among other PWID 
globally [11], suggesting that Kenya is indeed becoming an epi-center of drug-use related 
HIV epidemic. The significance of injecting drug use in driving the Kenyan HIV epidemic 
particularly manifest at the coast where nearly half of all PWID live, and 20.5% of these are 
infected with the virus [12].  
 
The rise in injecting drug use could further accelerate HIV transmission in Kenya, where HIV 
is already widespread among heterosexual adults, particularly women. In response to the 
phenomenon of injecting drug use, the Ministry of Health introduced a harm reduction 
approach within the National HIV/AIDS Strategic Plan in 2013 [13], largely comprising 
provision of needle and syringe exchange program (NSP), HIV testing, and opioid 
substitution therapy (OST) [4]. These interventions are based on the World Health 
Organization’s recommendations for a package of services for all PWID globally [13]. This 
package includes needles and syringes, opioid substitution therapy (OST; also referred to 
medically assisted therapy), drug overdose treatment, HIV testing, antiretroviral therapy 
(ART), condoms, health education, and treatment of sexually transmitted infections (STIs), 
tuberculosis (TB) and viral hepatitis [14].  
 
Despite the importance of gender in determining harms of drug use [15], and the increasing 
emphasis on injecting drug use within the national HIV program, relatively little data exists 
related to social contexts of injecting drug use among women [16]. In Kenya, elaborating the 
vulnerabilities to HIV among female drug users is particularly pertinent as women are 
generally more affected by HIV [4]. Overall, 6.9% of Kenyan women are infected with the 
virus compared to 4.4% of men [17]. In this context, women are inequitably affected by HIV 
partly due to gender inequalities, and other socio-cultural determinants such as early sex 
debut [18], gender-based sexual violence [19] and economic inequality in a patriarchal 
society [20]. 
 
Despite women being inequitably affected by HIV nationally, females that injecting drugs, –a 
practice that is a known risk of HIV [11] – have been relatively understudied. Although a 
number of investigators such as Guise et al. [21], Rhodes et al. [22], and Kurth et al. [12] 
have explored injecting drug use in Kenya, their study samples were predominantly male 
(74%, 70% and 85% respectively). Similar to the global situation [23], much of what is 
known about injecting drug use locally has been generated from male drug users. Cognisant 
of this gap Guise et al. [21] has called for studies to be conducted, exploring the 
‘vulnerability of women, and how drug-related harms are gendered or structured by gender 
relationships in this context’. This kind of data is needed to inform gender sensitive 
interventions for preventing HIV and other harms of injecting drug use among women. This 
is a current need, given that harm reduction programs are currently in development in much 
of East Africa [24]. Given the foregoing, the aim of this paper is to1) document HIV risks 
among women who inject drugs in coastal Kenya, and 2) discuss potential implications for 
services, policy and future research.  
 Methods 
Primary study aims and design 
This paper reports information generated through a secondary analysis of pre-existing 
qualitative data. The primary study [25, 26] was a qualitative study conducted in 2015 with 
aim of exploring the needs, barrier and determinants of sexual and reproductive health (SRH) 
of women who inject drugs in the Kenyan coastal towns of Mombasa and Kilifi. 
 
Aims, setting and methodology of primary data collection  
Data were collected through a combination of focus groups and interviews. Participants 
comprised of 45 women who inject drugs and 5 key stakeholders involved in provision of 
services to people who inject drugs. Of the 45 women, 24 participated in interviews (12 in 
each site) and 21 participated in three focus groups sessions (2 sessions in Mombasa and 1 
session in Kilifi). To be eligible, women had to be adults aged at least 18 years in order to 
provide independent consent; be within the reproductive age bracket of 18–49 years; and 
have injected drugs within the past 90 days, which was the definition of current injecting 
drug use in this study.  
 
The above participants were recruited through convenient sampling via two community-
based organisations (CBO). These CBOs were providing harm reduction services through a 
community-based outreach model whereby injecting drug users were provided with 
interventions in their own localities and neighbourhoods, or through walk-in services at drop 
in centres. Through this model of service provision, outreach workers and drop-in-centre staff 
provided injecting drug users with clean needles, syringes, drug addiction counselling, HIV 
counselling and testing, condoms, and a range of essential reproductive services, such as 
pregnancy tests and contraceptive pills. Injecting drug users that required additional services 
were referred to nearby government services.  
 
Women were approached and invited to participate by outreach workers during outreach, or 
by staff at drop in centres. Recruitment of participants was informed by saturation of data as 
specified in the primary study protocol. Prior to data collection, women were informed of the 
aim of the study and required to provide written consent. In the IDI and FGDs, women were 
asked to describe their needs related to their sexual and reproductive health, their drug use, 
HIV testing, and access to community and facility-based health services. At the end of the 
IDIs and FGDs, women were asked to fill a short questionnaire regarding their age, main 
source of income, marital/relationships status, drug use by their regular partner, condom use, 
HIV testing, contraception, prior experience of physical or sexual abuse, incarceration, and 
other social economic characteristics. To complement perspectives from women who inject 
drugs five stakeholders who were experienced in providing services to people who inject 
drugs were selected to participate in interviews related to above topics. The five stakeholders, 
three of whom were women, included a community health worker (n=1), outreach workers 
(n=2), a ministry of health official (n=1) and an outreach manager (n=1). These stakeholders 
were recruited purposely in collaboration with the two community-based organisations based 
on their expertise in community outreach, government policy, and harm reduction service 
resourcing and management. All IDIs and FGDs were conducted face-to-face- at the CBOs or 
stakeholders’ offices either in Swahili or English, based on participants’ preference. In 
addition, IDIs and FGDs were audio recorded and lasted between 45–60 minutes. Additional 
details regarding the primary data collection and analysis has been reported in in a series of 
several primary manuscripts [16, 25-27]. 
Social demographic profile of primary participants 
The social demographic profile of the sample has been published the above primary papers 
[16, 25-27]. In brief, the sample was relatively young (mean age 28.5 years), and poorly 
educated, with a fifth (18%) not having had formal education. Over half (53%) were single, 
while the rest either had a live-in partner (27%), or were married (18%). Most relied on sex 
work (29%), ‘hustling’, or casual labour for income. Over a quarter (27%) were homeless and 
over half (53%) had a history of being imprisoned. Most had at least one child, and did not 
use contraception, nor attend antenatal care when they got pregnant [25, 26]. Their access to 
sexual and reproductive health services was prevented by user fees, transport costs, and 
stigma [16, 25].  
Secondary data analysis 
The entire dataset from the primary sample was subjected to secondary analysis, based on a 
set of new secondary research questions, related to drug use and associated HIV risks. Using 
the primary dataset, drug use, injecting and sexual behaviours were summarized. Transcripts 
were imported into Nvivo®  (QSR International) [28], and emerging codes related to 
injecting or sexual risk behaviours identified guided by a theoretical framework, namely the 
social ecological model [29]. Codes were refined by continuously examining text segments 
for similarities and differences [30] and refined codes then organized to identify overarching 
descriptive and analytical themes [30]. Coding was conducted by one author, (GM).  
 
Theoretical approach: the social ecology theory  
Given the observation that ‘interventions are more likely to be effective if they are theory 
based—namely, if they draw upon a theoretical underpinning of the established determinants 
of behaviour’ [31], this study gave emphasis on theoretical elaboration of the nature of HIV 
risks to increase the likelihood that potential interventions would be effective. This is 
particularly relevant given that harm reduction programs are currently in development in 
Kenya, and indeed, much of East Africa [24]. Specifically, this study uses the social ecology 
theory, which hypothesizes that health behaviours are determined by people’s interaction 
with their physical, social and structural environments [32]. In his seminal work, Urie 
Bronfenbrenner [33] suggested that individual health and development was influenced by 
what he labelled micro, meso and exo environments. The social ecological model is 
illustrated as concentric circles each inside the next, representing successive domains of the 
social ecology [34]. Historically, the social ecology theory emerged in response to a critique 
of health promotion services that over-relied on individual-level interventions while failing to 
account for wider social determinants of health [32].  
 
Recently, similar critique has also been levelled against HIV prevention programmes. 
According to Baral et al. [35], theory-based elaboration of HIV risks tends to focus on 
personal and micro-contexts, ignoring macro-determinants of HIV-related risky behaviours. 
Consequently, Baral et al. [35] argues that social ecological approach is required, especially 
for key populations, whose HIV risks are affected by structural forces. While useful, popular 
health promotion theories such as social cognitive theory, health belief model and theory of 
reasoned action do not necessarily take into account the availability of social resources, and 
other protective factors situated within communities and how these determine individual 
health behaviours [36]. Yet, wider macro social and structural factors such as economics, law 
enforcement, culture, religion and politics also affect peoples’ health behaviours [29], 
including drug use [37]. 
 
The effects of macro-structural factors on health behaviours are particularly prominent in 
regard to HIV [35, 38]. In this regard, Baral et al. [35] argue that understanding and 
addressing the wider scope and multiplicity of determinants of HIV risks is essential to the 
control of the HIV epidemic. Indeed, existing studies exploring root causes of HIV risk 
suggest that common underlying determinants of HIV risks among injecting drug users and 
other key populations include individual biomedical factors such as circumcision, 
behavioural factors such as health seeking, and structural factors such as policing and health 
systems’ capacity [15, 35, 39]. For example, aggressive or discriminatory policing of 
marginalized or criminalized populations such as injecting drug users can cause them to share 
used needles, as they avoid to get arrested while obtaining clean needles [40, 41].  
 
Thus, elaboration of HIV behavior among women should capture broader ecological forces 
that influence their behaviours, taking into account potential resources, risks and protective 
factors located within their communities and wider macro-environments. Besides identifying 
influences of health behavior, the social ecology theory is also useful in the identification of 
potential solutions to ill health [32, 34], a function that is particularly suitable for the present 
study and its purpose of discussing potential implications on services, policy and research to 
mitigate HIV risks among women who inject drugs. The use of social ecology theory is also 
relevant in Kenya where harm reduction services are currently in development [24], and 
where – as we argue in this paper – the current harm reduction policy has predominantly 
focused on clinical interventions, with relatively limited focus on structural interventions. In 
this context, there is an opportunity for developing additional interventions for women who 
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Results  
Drug-use and sexual profile of participants 
As shown in the following Table 1, 96% of the participants had ever been tested for HIV. 
Over a fifth (22%) of the participants were HIV positive. Condom use among the sample was 
generally low: a third (31%) of participants were consistent condom users, a third (29%) were 
inconsistent condom users, and another third (31%) had never used condoms. Seven of the 
ten participants living with HIV were inconsistent condom users, while the others used 
condoms always (n=1) was not sexually active (n=1), or did not provide that information 
(n=1). Furthermore, 29% of the sample had drug-using partners. Of these 11% reported that 
their main sexual partners were drug injectors, while 18% had partners who smoked or 
snorted drugs. Notably, 20% (n=9) reported that their main sexual partner did not use any 
drugs. Furthermore, 29% reported a history of being sexually assaulted, and 48% had been 
exposed to physical and other forms of violence (Table 1). 
Table 1. HIV testing and sexual characteristics of the study sample. 
Characteristic IDI FGDs Total % 
HIV Testing      
Ever tested     
Yes  23 20 43 96% 
No  0 1 1 2% 
Unknown  1 0 1 2% 
Last tested     
In last month 2 5 7 16% 
1-3 months 13 9 22 49% 
3-6 months 3 2 5 11% 
Over 6 months 0 0 0 0% 
Over 1 year 5 4 9 20% 
Unknown  1 0 1 2% 
N/A  0 1 1 2% 
Where tested     
Outreach   4 9 13 29% 
Hospital/clinic 12 6 18 40% 
Drop-in-Centre  5 4 9 20% 
Prison  2 0 2 4% 
Unknown  1 1 2 4% 
N/A  0 1 1 2% 
Collected results     
Yes  23 19 42 93% 
No   0 1 1 2% 
Unknown  1 0 1 2% 
N/A  0 1 1 2% 
HIV status      
Positive  7 3 10 22% 
Negative  13 15 28 62% 
Unknown  1 2 3 7% 
Not willing to disclose 3 1 4 9% 
Main sexual partners drug use    
Injecting  4 1 5 11% 
Smoking   4 4 8 18% 
None  6 3 9 20% 
N/A  9 13 22 49% 
Unknown  1 0 1 2% 
Last time had sex     
Last 7 days  10 3 13 29% 
1-4 weeks  3 4 7 16% 
1-3 months  3 4 7 16% 
>3 months  5 10 15 33% 
Not disclosed 2 0 2 4% 
Unknown  1 0 1 2% 
Condom use     
Always  9 5 14 31% 
Sometimes 4 9 13 29% 
Never  10 4 14 31% 
Not disclosed 0 3 3 7% 
Unknown  1 0 1 2% 
Sexually harassed     
Yes  6 7 13 29% 
No  16 14 30 67% 
Not disclosed 1 0 1 2% 
Unknown  1 0 1 2% 
Sexually assaulted     
Yes  2 11 13 29% 
No  17 10 27 60% 
Not disclosed 1 0 1 2% 
Unknown  1 0 1 2% 
Other violence     
Yes  11 11 22 49% 
No  11 10 21 47% 
Not disclosed 1 0 1 2% 
Unknown  1 0 1 2% 




Results showed that HIV risks among the sample fell into two broad categories: sexual and 
injecting-related.  In keeping with the socio-ecological framework, identified influences of 
HIV risks were mapped onto individual, interpersonal, and societal-structural domains. 
 
Individual-level influences of risky behaviours 
Low risk perception 
Throughout IDIs and FGDs, women reported that they received health education from 
outreach workers related to HIV and harms of drug use. Participants stated that outreach 
workers “educate us” regarding “infections” (IDI participant, aged 24, Mombasa) and 
“how to stop drug addiction” (IDI participant, aged 26, Kilifi). Indeed, nearly all of the 
drug users had been contacted by outreach workers prior to the study, and seemed to be 
generally aware that sharing of needles increased the risk of acquiring HIV infection. Being 
cognizant of that sharing of needles was to be avoided, some IDI participants seemed 
defensive when asked whether they shared needles, with one claiming that “everybody uses 
their own needle” (IDI participant, aged 32 years, Kilifi). Despite this assertion however, 
data from FGDs revealed that sharing of syringes and needles was common. While IDI 
participants denied sharing injecting equipment with others, which could be due to social 
desirability bias, participants in focus groups openly described how needles were “going 
around” or “travelling” from person-to-person (FGD participant, Mombasa).  
 
Although women were more emboldened to acknowledge the presence of needle-sharing in a 
group context, some sought to distance themselves from this practice, suggesting that it was 
others that practised it, and not themselves. As an illustrative example, one participant 
claimed that “there are others who, if it is night and she gets a used needle on the road, and 
she is injecting, she would re-use it” (FGD participant, Mombasa). Despite this kind of 
self-distancing and ‘othering’, focus group participants agreed that sharing of injecting 
equipment was taking place “currently” (FGD participant, Mombasa). They stated that this 
practice was the reason why HIV was common amongst themselves: 
You find that one needle travels among approximately seven people. This issue is 
contributing a lot to HIV (FGD participant, Mombasa).  
 
Regardless of whether they attempted to conceal it or not, participants’ narratives indicated 
the presence of a disconnect between their attitude, knowledge and actual practice related to 
sharing needles. While they were clearly aware of the dangers involved, they continued to 
share needles on an ongoing basis. Exploration of the contradiction between knowledge and 
practice suggested that participants’ sharing of needles was due to a somewhat situational low 
perception of risk. For instance, one participant stated that her peers “think that the other 
person does not have the [HIV] virus, you say the needle is from your fellow, and that is why 
you see these issues of many infections come in” (FGD participant, Mombasa).  
 
Intersection of trust and gender norms within intimate partnerships 
Apart from being the underlying cause for needle-sharing, a low perception of risk also 
occurred within intimate partnerships. Due to this situational low risk perception, at six 
women had regularly participated in sexual activities that increased their risk of acquiring 
infections from their husbands and regular partners. As shown in Table 1, several women 
had stable partners who were also injecting drugs, mostly heroin. However, despite their 
intimate partners being at high risk of HIV on account of injecting drug use, women were not 
deterred from having unprotected sex with them, as might be noted in the following excerpt: 
Q: When was the last time you had intercourse when high on drugs?  
R: Last week.  
Q: Explain to me how it was.  
R: I was with my boyfriend, we just had it as usual, and we get intimate without a 
condom as I have no worries at all.  
Q: Is your boyfriend also a drug addict?  
R: Yes  
Q: How does he use drugs?  
R: He injects himself (IDI participant, aged 30, Kilifi).  
As may be deduced from above exchange, women routinely participated in unprotected sex 
and drug use during sex with their partners, due to a perception that their partners were 
uninfected. As such, the above women perceived no reason to worry. Other participant’s 
narratives indicated that this low-risk perception was deeply intertwined with women’s trust 
of their sexual partners. For instance, in response to a question regarding when she had last 
injected heroin during sex, a woman who had reported that she never used condoms stated as 
follows: “yesterday but one, when I was with my husband, the man whom I can trust” (IDI 
participant, aged 36 years, Kilifi).  
 Despite trust of sex partners playing a prominent role, the extent to which a couple’s sexual 
behaviours were under the full control of the women themselves was not always clear. 
Nevertheless, our findings showed that some participants were inadvertently getting exposed 
to HIV while in the pursuit of fulfil perceived ideals of a good sexual relationship with their 
men, whom they were expected to trust. A number of participants reported feeling compelled 
to take drugs in-order to facilitate good sex with intimate partners, especially when they were 
not in the mood for it, or after they had argued: 
Maybe you have differed, and for a long time you are not in the mood. You don’t 
have the feelings. So you see, your partner forces you to use. He tells me “hold these 
two, one for you to inject and the other I will inject, then we will [have sex]” (IDI 
participant, aged 21 years, Mombasa). 
 
As evident in the above excerpt, there were implicit and opposing interplays between 
women’s cognition and their behaviours with their sex partners. For instance, the above 
except implied this participant would not normally take drugs during sex, except to fulfil an 
expected sexual role. As was the case among most married or cohabiting women, the pursuit 
of expected sex with her intimate partner also meant that this participant would not use a 
condom with him. Referring to her husband, another woman mentioned that “whenever he 
comes home he brings some [drugs] along for me. I have to take drugs for me to feel 
pleasure. Without drugs, it is like you are forcing me” (IDI participant, aged 36 years, 
Kilifi).  As might be noted here, an inequitable cathexis and gender structure dictated that 
women were obligated to have sex with their men, and often to inject prior to sex as sex 
would otherwise be un desirable it. Suggesting that women were not adequately empowered 
to control their own exposure to risks, stakeholders gave examples of how intimate partners 
wielded powerful external influence over women. In this context, “bonding with spouses” 
was blamed for making women “go back to risky behaviours” (CBO Program Manager, 
Kilifi). In sum, risk perception, inequitable gender norms, and trust intersected to potentially 
expose these women to HIV. 
 
Interpersonal influences of risky behaviours 
Perils of transactional relationships and sex work 
In contrast to the low perception of risk of acquiring HIV infection from their husbands and 
regular partners, women who engaged in transactional relationships, whereby sex was 
exchanged for a variety resources, recognised that they were at high risk of HIV. Overall a 
smaller proportion of 18% of the participants were married, while 53% were single and 27% 
were cohabiting. Because single or cohabiting women tended to be in transactional sexual 
relationships, transactional sex was more prevalent among the sample as a whole, despite it 
being perceived as risky. Indeed, most single women regularly exchanged sex for drugs, 
protection from the police, and accommodation. In an illustration of how this typically 
occurred, a participant explained that “there are young men who usually sell. Sometimes you 
have lacked [drugs], and he sees you. He will tell you “have sex with me then I will give you 
a sachet. You can have 1 or 2 sachets, as long as you make me happy”, so you have to 
accept” (IDI participant, aged 26 years, Mombasa). In addition to a number of other 
similar accounts from six other women, several stakeholders also claimed that a large number 
of women were involved in transactional sexual relationships with peddlers: 
To sustain the addiction behaviour, they have to make friendly relationships with 
peddlers if they are going to get free drugs. Free in quotes. They have to give their 
bodies to the peddlers for them to get drugs (CBO Program Manager, Kilifi). 
 
In this context, it was usual that “when you have a relationship with someone like that, and he 
sells, he provides you with drugs so that you can make him happy [sexually]” (IDI 
participant, aged 26 years, Mombasa). Besides getting heroin her peddler boyfriend, this 
participant also explained that she also gained a significant amount of social capital from her 
boyfriend in exchange for sex. This social capital was created by the extensive social 
networks that most peddlers had, sometimes with the police. Explaining that peddlers were 
well connected socially, she explained that “in other ways, he protects me from the bad things 
that happen at the drug dens. He will be the first person to be informed if the police are 
arresting people. He tells me to leave, or we leave together. He cannot leave me to be 
arrested, you see!” (IDI participant, aged 26 years, Mombasa).  Despite these kinds of 
benefits, women who engaged in transactional sex were highly vulnerable to abuse by their 
sexual partners. Women’ accounts suggested that those who had transactional sexual partners 
were regularly raped by them, as might be deduced from the following quote:  
There is a guy who used to accommodate me because I could not afford to pay for a 
house. I used to see as if he used to force me to have sex with him, it’s like he used to 
rape me…as in, I didn’t like it. However, because it was rent, it was like a type of 
rent, it was compulsory for me to give it by way of sex. So I had to accept (IDI 
participant, aged 33 years, Kilifi).  
 Our data suggested that women who were engaged in transactional sexual relationships 
primarily to acquire for drugs or accommodation tended to maintain the same partner for 
some length of time. However, the most common form of transactional sexual relationships, 
took the form of sex work, where sex with multiple casual partners was exchanged for 
money. Sex work was the main occupation among 13 women, comprising 29% of the sample. 
Besides it being highly prevalent, some women reported having sex with more than ten men 
daily. Discussing the high turnover of their clients, one sex worker stated that “regarding 
men, we exchange with them like clothes” (FGD participant, Mombasa). Other participants 
illustrated the multiplicity of their sex partners by describing their sex life using phrases such 
as “I roam about” (IDI participant, aged 21 years, Mombasa), “I move here and there” or 
“I move like a bird” (IDI participant, aged 26 years, Mombasa). Besides multiplicity of 
sexual partners, specific situations in which women were potentially exposed to infections 
were described: 
To tell the truth, whenever I have no money to buy drugs, I go and sell my body. At 
times when I go for prostitution, accidents happen, like a time when the condom 
burst. In another incident, I had a client, but I realised that I didn’t have a condom, but 
because I needed the money, I performed a blowjob without a condom (IDI 
participant, aged 30 years, Kilifi). 
 
Drug use during sex work 
The above sexual risks were aggravated by injecting of heroin during sex work. Engaging in 
sex while high on drugs - colloquially referred to as ‘being steam’, was seen as essential by 
almost all the 13 women involved in sex work in our sample. They claimed that injecting 
drugs during sex work enabled them to bear the shame of it: 
I usually have sex when I am steam. It is very hard for me to have sex when I am 
sober because when I do sex work, I am in business, it is not something that I wish to 
do. So I have to use drugs and be steam so that I am not shy when I do sex work (IDI 
participant, aged 26 years, Mombasa). 
However, because most participants regularly lacked money to purchase drugs, they 
frequently asked their prospective clients to buy drugs for them prior to sex, which further 
exacerbated the risks associated with drug injecting and sex work by weakening their ability 
to bargain for safer sex: 
If a man wants to have sex with me and at that time I have not injected, then I tell him 
“I cannot go with you because I have not injected yet”. He then he takes me to get 
drugs, but I am obliged to have sex with him. We use the drugs together, then he uses 
me later (IDI participant, aged 30 years, Kilifi). 
 
Intersections of sex work, gender violence, and power 
As might be noted above, participants felt disempowered and commoditised, particularly 
because they were unable to negotiate for condom use when intoxicated. Furthermore, our 
data suggested that once clients bought drugs for them, women were left even more 
vulnerable to sexual violence at the hands of their clients. Indeed, a third of the women, most 
of who were involved in sex work had experienced sexual harassment or assault (Table 1). 
Accounts from six of these participants showed that being cajoled to have condom-less sex 
was the norm, and this often morphed into rape or physical violence:  
The work we do… we are at high risk. Sometimes you go with someone, and he is 
rough, or wants to use you and doesn’t want to pay you. If you resist, you are beaten. 
He tells you “I want to have sex without a condom.” If you refuse, he will bring chaos 
(IDI participant, aged 24 years, Mombasa).  
 
Nearly half of the women reported having experienced some form of violence, usually after 
they did not yield to demands for condomless sex from clients. Commenting on the regularity 
of rape, one sex worker who often had sex while high on heroin described a recent incident of 
her own: 
I had injected myself such that I didn’t know myself. The following morning is when 
I found out that I had been raped. Do you understand? I realised that I didn’t have 
clothes, I couldn’t do anything, I couldn’t even walk, I was bleeding. Afterwards, 
outreach workers from REACHOUT came to pick me and took me to the hospital. By 
good luck, I was tested for HIV and found that I didn’t have it (IDI participant, aged 
21 years, Mombasa).  
 
As illustrated in the preceding excerpts, participants who engaged in sex work were aware of 
the risks associated with it, such as HIV. Clearly, most of them preferred to use condoms 
with their sex work clients, with one stating that she would insist that “they pay me for sex 
but using a condom” (IDI participant, aged 26 years, Kilifi). Another stated: 
Yes, sex work is my job, but even if it is my job, I always protect myself so much. I 
usually have sex with someone using a condom; if there is no condom, I don’t have 
sex (IDI participant, aged 21 years, Mombasa). 
 
Despite being cognizant of the risks, data suggested that these women were frequently 
precluded from practising safer sex. One sex worker narrated how she used to insert male 
condoms into her vagina in an attempt to minimise potential risks, having little power to 
ensure that her clients used condoms: 
They insist that they don’t want to use condoms, so at times I agree because of arosto 
[withdrawal], but I take the male condom, tear it and insert it into my vaginal tract, so 
that when he ejaculates inside, the sperms do not penetrate through and bring 
infections. I don’t know if this helps or not? (IDI participant, aged 30, Kilifi).  
 
Societal-structural influences of risky behaviours 
Economic influences of risky behaviours 
In spite of sex workers’ determination to protect themselves from sexually transmitted 
infections, economic considerations compelled them to abandon their condom use. 
Describing a typical scenario where this occurred an FGD participant stated that: 
Another one tells you, “I have one thousand shillings, but I don’t want to use a 
condom, but if you want sex with a condom, I will give you two hundred shillings” 
Now you are compelled; seeing that the one thousand is a lot, you are forced to do it 
without a condom (FGD participant, Mombasa). 
 
Furthermore, data suggested that most participants entered into sex work due to joblessness 
and poverty. Five women of varying ages blamed lack of jobs for their entry into sex work, 
with one stating that “sex work has been my main means of getting money to use” (IDI 
participant, aged 26 years, Mombasa). Another lamented that “[Because] I don’t have a 
job, I sleep with any man as long as he has money” (IDI participant, aged 33 years, Kilifi). 
Given the fact that most of her peers were jobless, another participant suggested that sex 
work was inescapable, claiming that “It behoves to engage in sex work” (IDI participant, 
aged 30 years, Mombasa).  
 
Despite the economic benefits, women rued the fact that sex work exposed them to HIV, yet 
it was nearly inescapable as they needed income. To illustrate this, one participant described 
“sucking in blowjob”, “condoms bursting”, “having sperms in my mouth” and other forms of 
accidents, but she quickly added that “I didn’t mind if there are any risks because I was in 
need of the money for buying drugs” (IDI participant, aged 30 years, Kilifi). Others in 
FGDs rued participating in unwanted sexual practices, yet they felt forced by economic 
circumstances to engage in it. Supporting comments from other FGD participants, one sex 
worker narrated how her clients would often demand unprotected anal sex, stating “‘I don’t 
want in front, I want behind’. In other words, he forces you, but you want that money, so you 
are forced to close your eyes” (FGD participant, Mombasa). Even when women had 
opportunity to use condoms with clients, they stated how economics caused them not to use 
them. In theory, outreach workers were supposed to distribute free condoms, but there were 
times when women had run out of them, and needed to purchase them. Here, economics 
barred these women from practicing safe sex, as explained by following participant, who was 
also HIV positive and was keen to use condoms:  
There are times we lack free condoms, and you are forced to buy, but at times it is 
hard: you have come onto the street, and you don’t even have 10 shillings to buy one. 
That is where the problem comes in (IDI participant, aged 26 years, Mombasa).  
 
Inequitable gender expectations and vulnerabilities 
Indeed, and perhaps because they were aware of the risks involved, women often took upon 
themselves the responsibility of ensuring that a condom were used during sex work. Given 
their financial impoverishment however, they were generally unable to avail condoms. 
Despite being able to afford condoms, their male clients normally preferred condom-less sex, 
however, and regularly took advantage of women’s lack, as explained by the above sex 
worker who was living with HIV: 
He will take that opportunity and say “it is not my fault that you don’t have it, so let’s 
proceed” (IDI participant, aged 26 years, Kilifi).  
This kind of situation may have created conditions for clients to acquire HIV from infected 
sex workers. These finding suggested that the presence of differential gender responsibilities 
and expectations related to provision of condoms created opportunities for HIV transmission, 
fueled by economic inequalities. In effect, these gendered economic inequalities made 
women more vulnerable, as they were often unable to provide condoms, and control their 
risks. 
 
Underscoring the issue of gender vulnerability was the observation that most of the peddlers 
at the study towns were male: only three of the 45 women in our sample were peddlers. 
Women were regularly exploited by male peddlers who were known to have multiple 
transactional sex partners and to use drugs too. Thus, the predominance of men in peddling 
added a further vulnerability to the gendered risks that confronted women, since peddlers had 
an upper hand: 
You can go to borrow drugs on credit, and they tell you “what use is it to borrow? If 
you can sleep with me, I will give you even more.” But because you have arosto 
[withdrawal] you are forced to do as he wishes (IDI participant, aged 30 years, 
Kilifi).  
Just like other male clients of sex workers, male peddlers frequently demanded that 
transactional sex was condom-less. One participant who was HIV positive (mentioned 
previously) explained that “normally at the drug injecting dens, where someone gives you 
drugs in exchange of sex, mostly we don’t use condoms” (IDI participant, aged 26 years, 
Mombasa).  
 
Indeed, a program manager at a community-based organization noted how the convergence 
of addiction and the possibility that women could always engage in sex work increased their 
exposure to infections, asserting that, “women are vulnerable because of sex work and their 
need to use drugs” (CBO Program Manager, Kilifi). Thus, although women seemed to 
benefit economically from their transactional relationships with peddlers and other partners, 
this benefit was paradoxical in that it harmed them in other ways. In the words of this 
stakeholder, “women see the peddlers and the spouses as their main backbone of support 
although in the real sense they are not” (CBO Program Manager, Kilifi).  
 
Intersecting gender, economic and health system influences 
While the emphasis here was on the women’s economic needs, these influences occurred 
alongside others, including interpersonal influences. For example, women reported that they 
were compelled to engage in sex work to support their own and their partners’ drug use. In 
situations when men lacked drugs, they regularly required their women to “go and hustle” 
(IDI participant, aged 30 years, Mombasa). Similar to three others, this participant was 
cognisant of her partner’s economic dependency on her, brought about her gender-related 
ability to engage in sex work, asserting that “I am the one he is using as a means of survival” 
(IDI participant, aged 30 years, Mombasa). Another participant who had been involved in 
transactional sex for accommodation (mentioned previously) narrated how her partner (who 
was a cocaine user) also required her to get drugs for him, in addition to sex in exchange for 
accommodation. Noting the paradoxical shift, she narrated stressed that: 
So it became I who was hustling. I could go to him for accommodation, but he did not 
have any means of getting drugs. He too stays and waits for me, it as if he were my 
child. So it’s as if I am paying him through sex and by looking for what he will use 
for buying his cocaine. And it’s been a daily routine. I feel very annoyed, but I have 
no other choice (IDI participant, aged 33 years, Kilifi). 
 
Thus economic pressure, and a reluctance of male partners to cater for themselves, and their 
spouses intersected with gender vulnerability to enhance risks that women were exposed to. 
Indeed, an outreach worker highlighted the confluence of these influences: 
If a woman is into drugs, the risk is high, because they have double or multiple issues. 
They can do drugs, they can have a sexual partner who is a drug user, and at the same 
time, they might be involved in sex work with multiple other sex clients as well. So 
the risk is very high (CBO Outreach Worker, Mombasa). 
 
Underscoring the issue of intersecting influences was the observation that apart from 
propelling sex work, economic factors intersected with health system factors to increase 
unsafe injecting practices. Asked to provide specific situations in which sharing of needles 
took place, a focus group participant explained that needle sharing frequently occurred “at 
night” when PWID commonly run out of clean needles (FGD participant, Mombasa). 
Another FGD participant elaborated that in these situations, women’s decisions regarding 
sharing needles depended on “whether the chemist is still open” and whether they had 
“money to buy [syringes]” (FGD participant, Mombasa). Due to their economic 
impoverishment however, few could afford to purchase injecting equipment. Hence, although 
outreach workers did provide these commodities freely, they were inadequate to meet 
women’s needs throughout the day and night. This poor health services organisation 
intersected with economic pressures to produce unsafe injecting practices. This observation 
of intersection was consistent with patterns observed in regard to other drivers of risky sexual 
behaviours. In sum, women encountered diverse HIV risks emanating from their sexual and 
injecting behaviours, and which were produced by intersecting influences in their social 






This paper reports HIV risks encountered by female injecting drug users in the Kenyan 
coastal towns of Mombasa and Kilifi. An important contribution of our study is in elaborating 
the social contexts of injecting drug use and attendant HIV risks among a relatively under-
studied population of female injecting drug users in Kenya. In our study, HIV risks among 
women who inject drugs fell into two broad categories: sexual and injecting-related. Our 
sample of women were regularly exposed to potential HIV infection via unsafe sexual and 
injecting practices. Not surprisingly, a fifth of them were already infected with HIV at the 
time of the study. At the most primary level, our study demonstrates the range of behaviours 
that expose women to HIV, including unsafe injecting practices, unprotected oral, vaginal 
and anal sex, sex while high on drugs, forced sex/rape, sex work, and other forms of 
transactional sex. 
 
With the possible exception of having sex while high on injected drugs, the rest of these risky 
injecting and sexual practices have been widely documented in other studies. For instance, in 
Vietnam and Malaysia and Tanzania several studies have reported unprotected vaginal, oral, 
and anal sex as well as unsafe injecting among female injectors, in the context of intimate 
sexual relationships and sex work [42-44]. Sex work is particularly determinant of HIV 
acquisition among female injectors [45]. Despite the consistency of our findings with the 
above studies, our study makes novel contribution to literature by documenting the practice 
and gendered motivation of having sex while high on drugs among local women who use 
drugs. While accounts of people  engaging in sex while intoxicated with drugs exist in the 
literature, these typically feature men who have sex with other men [46, 47] and these 
predominantly use oral party drugs such as Mephedrone, crystal meth (Ecstasy) or 
Gammahydroxybutrate (GHB), rather than opioids [48-51].  
 
Here, our study distinguishes the motivation for having sex while high on drugs among our 
female sample, to that documented among gay men. While the primary motivation for this 
practice among gay (and potentially other) men is to enhance sexual performance and 
pleasure [52], it was primarily used by the women in our study to cope with the shame and 
rigors of sex work. A few participants in our study also injected drugs to enable them 
fulfilling their sexual obligations to their intimate partners. As such our study extends 
existing literature by distinguishing the gendered purpose of drug use during sex, by showing 
how motivation for this practice differs by gender. This divergence notwithstanding, our 
study’s findings are similar to those conducted among gay men, in showing that drug use 
during sex was linked with a limited use of condoms. Given the prevalence of sex work, and 
its association with poor condom use among women who inject drugs in our study, the use of 
drugs during sex should be considered an important HIV risk behaviour locally. This is 
particularly relevant given that injecting drug use is becoming more prevalent in Kenya [9], 
and interventions for PWID are still nascent [24].  
 
A critical finding from our study was the convergence and intersection of underlying social 
ecological determinants of HIV risks. Unsafe sexual and injecting were produced at the 
intersection of low-risk perception, inequitable gender norms and power, economic pressures, 
and poor availability of condoms and needles. Risky sexual behaviors were natural 
exigencies of injecting drug use in the context of scarce economic resources, supporting 
claims that epidemics of substance abuse and HIV occur as intertwined and synergistic 
phenomenon, often mediated by sexual violence [53]. For example, both scarce economic 
resources and inequitable gendered power determined ways in which sex work increased HIV 
vulnerability, for example by making it condom-less, or laden with sexual violence. At the 
same time these risks were aggravated by inadequate supply of condoms due to poor health 
service organization. 
 
In sum, individual, interpersonal and societal-structural determinants intersected to fashion 
HIV risks that women were exposed to in the course of their injecting drug use. This 
intersection of multiple drivers of risk created an environment laden with opportunities for 
women to acquire or transmit HIV, and is consistent with the presence of an ‘HIV risk 
environment’ within the study context. Not surprisingly a fifth of the women were already 
infected with HIV. This convergence of determinants of HIV risk is consistent with Rhodes’s  
[54] assertion that ‘harm from drug use is contingent upon social context, comprising 
interactions between individuals and environments’.  
 
Implications for practice, policy and research 
Given the findings of multiple intersecting determinants of HIV risks, a combination of 
individual, interpersonal and structural interventions would be needed to mitigate them. From 
a theoretical perspective, the assumption is that ‘multilevel interventions should be most 
effective in changing behaviour’ [29]. As such, regardless of their specific nature 
interventions to mitigate HIV risks should as much as possible be combined, bearing in mind 
that that just as determinants of risky behaviour intersect with each other, interventions are 
also likely reinforce each other.  Table 2 summarizes some of the interventions that we 
suggest could be implemented in a combined fashion to mitigate the various risks identified 
in our study.  
 
Table 2. Determinants and potential mitigations of HIV risks 
Social ecological 
domain 
Determinants of HIV risk Potential mitigation 
Individual 
• Coping with sex work  
• Low-risk perception 
• Self-efficacy training 
• Risk assessment skills 
Interpersonal 
• Inequitable gender power 
• Trust of sexual partners 
• Couple counselling 
• Gender transformation 
Societal structural 
• Poor availability of NSP 
services  
• Unemployment/poverty 
• Expansion of NSP services 





At the individual level, focusing on self-efficacy, rather than just on education regarding risks 
as is the case currently, is required. Our findings show that despite being aware of various 
HIV risks, participants’ behaviors were incongruent to their knowledge. Besides the notable 
diversity and co-occurrence of HIV risks, an important feature was the involuntary way in 
which they were experienced by women, in a context of inequitable gender power and norms. 
Thus, focusing on individual and collective self-efficacy could impart actual skills and 
competencies to enable women change their injecting behaviour, or avert potential sexual 
violence. These suggestions are supported by research showing that improved self-efficacy 
reduces adolescent substance abuse [55]. Strengthening women’s self-efficacy is particularly 
relevant given that they were often involuntary exposed to HIV due to inequitable gender 
power. For the most part, married and cohabiting women placed significant emotional 
importance on their relationships and attendant gender expectations, while those in 
transactional sex were insufficiently empowered to control their exposure to sexual risks 
imposed on them by men. Even when sexual and injecting risks were understood by the 
women, both economic and emotional considerations within intimate relationships and sex 
work tended to override concerns regarding potential infection. These dynamics clearly 
affected both women's HIV risk-taking and risk management, and supports our suggestion 
that strengthening women’s efficacy to behave based on their assessment of risk is essential. 
 
Interpersonal interventions  
At the same time, it is nearly impossible to adequately empower these women to adopt safer 
sex and injecting practices without addressing both the gender and economic drivers of these 
risky behaviours. As shown in this and other manuscripts from our sample [56], intimate sex 
partners wielded significant influence on women’s sexual and injecting behaviours, which 
need to be addressed. To start with, adopting couple-based approach to reaching injecting 
drug users would be useful in mitigating inequitable gender power, by creating opportunities 
for couple counselling regarding dangers of drug in the context of condom-less sex. Existing 
research shows that couple-based approaches are an effective in preventing HIV because of 
their ability to transform micro-social contexts of HIV risks among PWID in intimate 
relationships [57, 58]. For those who have a low risk perception, interventions to facilitate 
objective risk identification would be useful, as also proposed in India [59]. Because gender 
norms that encourage men to make decisions for their families are prevalent in the study 
context [56], additional interventions to transform inequitable gender norms should 
complement couple-based approaches. For example, strategies such as community 
conversations that focus on educating wider communities can provide good ground for 
dismantling harmful gender norms which seemed to create expectations that only women are 
responsible for safer sex. Community conversations have been applied to transform 
reproductive health behaviors in the study context [60].  
 
Societal-structural interventions 
Given the consistency of our findings with Rhodes’ [54] concept of ‘risk environments’, an 
important recommendation from our study is that upstream structural interventions for female 
injectors should be incorporated into harm reduction services. Currently, and similar to the 
situation in other countries [35], harm reduction services in Kenya tend to over-rely on 
individual and interpersonal interventions while ignoring structural interventions. The 
National Guidelines for the Comprehensive Management of the Health Risks and 
Consequences of Drug Use prescribe the harm reduction package recommended by the 
World Health Organization [14], with practical emphasis on the provision of clean needles, 
education and methadone [13]. The National Protocol for Treatment of Substance Use 
Disorders also emphasizes downstream services such clinical treatment and outreach [61]. 
These recommendations are of course relevant given our findings showing that a need for 
clean needles and condoms exists. However, less thought-of influences such as joblessness 
gender inequalities in economic power, and a lack of accommodation were also influential.  
 
Therefore, to adequately mitigate injecting and sexual HIV risks among women, it is essential 
to address the underlying gender and economic determinants. For example, promoting 
women’s financial independence should be an essential part of HIV prevention. Incorporating 
livelihood, employability, microfinance and low threshold-housing into harm reduction could 
cushion women from negative influences of their intimate partners [56]. Existing evidence 
shows that women injectors who are better off financially through livelihood and 
microfinance interventions are more able to better control their condom use, needle sharing, 
and numbers of sex work clients [58, 62].   
 
At the same time, strengthening health systems is needed to ensure universal accessibility of 
clean needles, including at night when sharing of used needles was reported to be prevalent. 
Instead of PWID having to buy syringes from pharmacies, allowing free distribution of 
syringes at pharmacies could be explored as an alternative service and policy option. Free 
distribution of syringes via pharmacies, together with provision of methadone, residential 
drug treatment, and designated safe-injecting spaces (shooting galleries) feature in countries 
with advanced harm reduction services [63]. As such, policy shifts will be required in Kenya 
to integrate macro-structural interventions while ensuring universal coverage of downstream 
harm reduction services. Both micro- and macro-interventions should be provided in an 
integrated fashion, incorporating the recommended package of harm reduction and HIV 
services as emphasized by others [64, 65]. Indeed, the social-ecological approach utilized in 
this study challenges the idea that determinants of drug use operate in isolation, and therefore 
asserts that interventions should be interconnected or linked [33]. 
 
Limitations 
Participants in our study were recruited via two community-based organisations. As a such, 
our findings may not reflect the experiences and perspectives of women who are not in 
contact with such community-based harm reduction services. In addition, similar to other 
studies of drug use [66], social desirability bias may have affected our findings, given the 
sensitive and personal nature of injecting and sexual risks that the IDIs and FGDs involved. 
Furthermore, this study may still be affected by interpretation bias stemming from the 
background and experiences of the coder (GM). Because this secondary analysis was based 
on PhD studies, it was not possible for more than one researcher to code the transcripts. 
However, the use of an established social ecological theoretical framework to guide the 
interpretation, combined with rigorous and transparent coding methodology mitigated 
potential bias. Despite residual limitations that may exist, this study contributes to a better 
understanding of women’s injecting contexts, which can inform both gender-sensitive 
interventions, and future studies. 
 
Conclusion 
Although women constitute a third of all drug users globally [67], they are disproportionately 
underrepresented in studies of drug use [23], including in Kenya, where previous study 
samples have been predominated by men. Our study successfully advances the application of 
secondary analysis in qualitative research to elaborate determinants of HIV risks among 
women who inject drugs, using the social ecology theory. Participants were highly vulnerable 
to acquiring HIV infection via sexual and unsafe injecting practices, and a fifth of them were 
already infected with HIV. Findings show that women’s risks to HIV should be viewed 
broadly as a product of their social ecologies, extending from their personal circumstances, 
relationships, and social-structural contexts. These findings support assertions that HIV and 
other harms of injecting drug use are deeply embedded in injectors environment. This 
environment created opportunities for women to acquire or transmit HIV and is consistent 
with the presence of an ‘HIV risk environment’ within the study context.  To address the 
convergence of determinants of HIV risks, a combination of interventions spanning women’s 
ecology should be central to harm reduction and HIV programs, with emphasis on upstream 
interventions that have hitherto received limited attention.  
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Figure 1: HIV risks were produced by intersecting influences in women’s social ecologies. 
 
